LGND Filings

SEC Filings
25 filings found
Filing DateFormAccession #View
2026-11-101440001957799-26-000200SEC →
2026-11-10SCHEDULE 13G/A0000914208-26-000430SEC →
2026-11-0640001376960-26-000006SEC →
2026-11-041440001957799-26-000193SEC →
2026-11-0440001950232-26-000006SEC →
2026-11-0340001376960-26-000005SEC →
2026-11-03SCHEDULE 13D/A0001193125-26-445875SEC →
2026-11-021440001957799-26-000192SEC →
2026-10-301440001950047-26-010515SEC →
2026-10-301440001949846-26-000627SEC →
2026-10-3010-Q0000886163-26-000060SEC →
2026-10-298-K0000886163-26-000058SEC →
2026-10-0640001950232-26-000003SEC →
2026-09-2440002001011-26-000142SEC →
2026-09-248-K0000886163-26-000054SEC →
2026-09-228-K0000886163-26-000050SEC →
2026-09-1440002001011-26-000140SEC →
2026-09-101440001950047-26-009263SEC →
2026-09-0840002001011-26-000137SEC →
2026-09-031440001950047-26-009091SEC →
2026-09-028-K/A0000886163-26-000048SEC →
2026-08-1440002001011-26-000115SEC →
2026-08-1440002001011-26-000114SEC →
2026-08-13SCHEDULE 13G0000914208-26-000299SEC →
2026-08-121440001950047-26-008026SEC →
10-K Annual Report
Loading section...
Risk Factors
Loading risk factors...
Ligand Pharmaceuticals (LGND) — Filings